SCHEMBL25545401

SCHEMBL25545401

CC(C)CC(O)c1ccc(OC(F)F)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ ADRB3 P13945 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ GFER P55789 1/20 0.39
▸ ADAM17 P78536 1/20 0.39
▸ PKM P14618 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ AOC3 Q16853 2/20 0.38
▸ DAGLA Q9Y4D2 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ ACACB O00763 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ DRD1 P21728 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25549614 0.82 AOC3 (0.40) ADRB3AOC3ALDH1A1MAPT
SCHEMBL18290856 0.81 LMNA (0.50) MEN1KMT2AADRB3GAAMAPK1
SCHEMBL11251522 0.79 AOC3 (0.58) MEN1KMT2AGAAMAPK1L3MBTL1
SCHEMBL18290854 0.79 KMT2A (0.45) MEN1KMT2AGAAMAPK1ALOX15
SCHEMBL6285397 0.78 TAAR1 (0.53) MEN1KMT2AADRB3MAPK1ALOX15
SCHEMBL25550486 0.77 AOC3 (0.39) MEN1KMT2AGAAMAPK1ALOX15
SCHEMBL28510777 0.76 NQO1 (0.52) MEN1KMT2AMAPK1L3MBTL1LMNA
SCHEMBL13859551 0.76 CYP17A1 (0.45) MEN1KMT2AGAAMAPK1ALOX15
SCHEMBL11530059 0.75 AOC3 (0.53) MEN1KMT2AGAAAOC3ALDH1A1
SCHEMBL16673700 0.75 AOC3 (0.53) MEN1KMT2AAOC3HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118103368-A EIF4E inhibitors and uses thereof 皮克医疗公司 2024-05-28 — — CN disclosed
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF PIC Therapeutics, Inc. 2023-05-18 — — US disclosed
CN-112321440-B Amino phenyl ketone compound and preparation method and application thereof 南方医科大学 2021-09-24 — — CN disclosed
CN-112321440-A Amino phenyl ketone compound and preparation method and application thereof 南方医科大学 2021-02-05 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150997-A1 EIF4E INHIBITORS AND USES THEREOF EIF4E, EIF4EBP1, EIF4A1 MEN1 2104/4885KMT2A 1931/4885ADRB3 4856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback